197 related articles for article (PubMed ID: 31851190)
1. [The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2019; 81(6):34-40. PubMed ID: 31851190
[TBL] [Abstract][Full Text] [Related]
2. [Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2018; 80(6):22-28. PubMed ID: 30585589
[TBL] [Abstract][Full Text] [Related]
3. [Tissue collagenase MMP-14 and endogenous regulators of its activity in the corpus uteri in squamous cell carcinoma of the cervix].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2017; 79(6):36-42. PubMed ID: 29265076
[TBL] [Abstract][Full Text] [Related]
4. Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.
Solovyeva NI; Timoshenko OS; Kugaevskaya EV; Gureeva TA
Mol Biol Rep; 2021 Oct; 48(10):6879-6886. PubMed ID: 34495460
[TBL] [Abstract][Full Text] [Related]
5. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
Xu Q; Cao X; Pan J; Ye Y; Xie Y; Ohara N; Ji H
Eur J Gynaecol Oncol; 2015; 36(5):539-45. PubMed ID: 26513879
[TBL] [Abstract][Full Text] [Related]
7. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
8. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Huang T; Chen MH; Wu MY; Wu XY
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
[TBL] [Abstract][Full Text] [Related]
9. Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
Sato T; Ota T; Watanabe M; Imada K; Nomizu M; Ito A
Gynecol Oncol; 2009 Aug; 114(2):337-42. PubMed ID: 19427027
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
Sier CF; Zuidwijk K; Zijlmans HJ; Hanemaaijer R; Mulder-Stapel AA; Prins FA; Dreef EJ; Kenter GG; Fleuren GJ; Gorter A
Int J Cancer; 2006 Jun; 118(12):2991-8. PubMed ID: 16425263
[TBL] [Abstract][Full Text] [Related]
11. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
[TBL] [Abstract][Full Text] [Related]
12. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
Tomita T; Nakase T; Kaneko M; Shi K; Takahi K; Ochi T; Yoshikawa H
Arthritis Rheum; 2002 Feb; 46(2):373-8. PubMed ID: 11840439
[TBL] [Abstract][Full Text] [Related]
13. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
16. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Cao Z; Xiang J; Li C
Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
[TBL] [Abstract][Full Text] [Related]
17. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
[TBL] [Abstract][Full Text] [Related]
18. [Interstitial collagenase and their endogenous regulators in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Solovyeva NI
Biomed Khim; 2017 Nov; 63(6):513-519. PubMed ID: 29251612
[TBL] [Abstract][Full Text] [Related]
19. [Matrix metalloproteinases 2 and 9, their endogenous regulators, and angiotensin-converting enzyme in cervical squamous cell carcinoma].
Timoshenko OS; Kugaevskaya EV; Gureeva TA; Zavalishina LE; Andreeva YY; Solovуeva NI
Arkh Patol; 2015; 77(5):31-35. PubMed ID: 26978018
[TBL] [Abstract][Full Text] [Related]
20. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
